The store will not work correctly when cookies are disabled.
N4-(3-aminopropyl)-5-iodo-N2-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
ID: ALA4761770
PubChem CID: 162659965
Max Phase: Preclinical
Molecular Formula: C16H22IN5O3
Molecular Weight: 459.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(Nc2ncc(I)c(NCCCN)n2)cc(OC)c1OC
Standard InChI: InChI=1S/C16H22IN5O3/c1-23-12-7-10(8-13(24-2)14(12)25-3)21-16-20-9-11(17)15(22-16)19-6-4-5-18/h7-9H,4-6,18H2,1-3H3,(H2,19,20,21,22)
Standard InChI Key: NMFNYBHGQPGMHJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
4.3159 -24.9766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0320 -23.7359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0307 -24.5648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7468 -24.9787 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4647 -24.5646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4620 -23.7326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7453 -23.3225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1798 -24.9761 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8936 -24.5626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6072 -24.9787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3206 -24.5659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3199 -23.7400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5998 -23.3286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8894 -23.7439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5958 -22.5037 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3082 -22.0877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0333 -23.3255 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7489 -23.7361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0355 -24.9778 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0362 -25.8028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6018 -24.5635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8869 -24.9753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1729 -24.5621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4580 -24.9739 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3176 -23.3235 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
5 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
13 15 1 0
15 16 1 0
12 17 1 0
17 18 1 0
11 19 1 0
19 20 1 0
3 1 1 0
1 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
2 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 459.29 | Molecular Weight (Monoisotopic): 459.0767 | AlogP: 2.61 | #Rotatable Bonds: 9 |
Polar Surface Area: 103.55 | Molecular Species: BASE | HBA: 8 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.58 | CX Basic pKa: 9.82 | CX LogP: 1.95 | CX LogD: -0.37 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.39 | Np Likeness Score: -0.78 |
References
1. Sun D,Yang Z,Zhen Y,Yang Y,Chen Y,Yuan Y,Zhang L,Zeng X,Chen L. (2020) Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer., 208 [PMID:32961380] [10.1016/j.ejmech.2020.112782] |